If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...
Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...
Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.
After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...
You may have COPD if you notice persistent, prolonged changes to your breathing. Symptoms can include: These symptoms usually worsen over time without treatment. You can also develop conditions ...
A recent study conducted by researchers from Seattle-based University of Washington and Durham, N.C.-based Duke University found a strong association between the use of fall-risk increasing drugs and ...
Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...
Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.